INKT
Price
$0.75
Change
-$0.04 (-5.06%)
Updated
Nov 14 closing price
124 days until earnings call
VINC
Price
$0.30
Change
-$0.02 (-6.25%)
Updated
Nov 14 closing price
137 days until earnings call
Ad is loading...

INKT vs VINC

Header iconINKT vs VINC Comparison
Open Charts INKT vs VINCBanner chart's image
MiNK Therapeutics
Price$0.75
Change-$0.04 (-5.06%)
Volume$28.26K
CapitalizationN/A
Vincerx Pharma
Price$0.30
Change-$0.02 (-6.25%)
Volume$417.4K
CapitalizationN/A
INKT vs VINC Comparison Chart
Loading...
INKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
INKT vs. VINC commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INKT is a Hold and VINC is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (INKT: $0.75 vs. VINC: $0.30)
Brand notoriety: INKT and VINC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INKT: 84% vs. VINC: 67%
Market capitalization -- INKT: $29.65M vs. VINC: $9.26M
INKT [@Biotechnology] is valued at $29.65M. VINC’s [@Biotechnology] market capitalization is $9.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INKT’s FA Score shows that 0 FA rating(s) are green whileVINC’s FA Score has 1 green FA rating(s).

  • INKT’s FA Score: 0 green, 5 red.
  • VINC’s FA Score: 1 green, 4 red.
According to our system of comparison, VINC is a better buy in the long-term than INKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INKT’s TA Score shows that 6 TA indicator(s) are bullish while VINC’s TA Score has 5 bullish TA indicator(s).

  • INKT’s TA Score: 6 bullish, 3 bearish.
  • VINC’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, both INKT and VINC are a good buy in the short-term.

Price Growth

INKT (@Biotechnology) experienced а +2.01% price change this week, while VINC (@Biotechnology) price change was -6.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

INKT is expected to report earnings on Mar 19, 2025.

VINC is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INKT($29.7M) has a higher market cap than VINC($9.26M). INKT YTD gains are higher at: -29.907 vs. VINC (-72.542).
INKTVINCINKT / VINC
Capitalization29.7M9.26M321%
EBITDAN/AN/A-
Gain YTD-29.907-72.54241%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
INKTVINC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
INKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X90584.1640002628.351600
+2.99%
Bitcoin cryptocurrency
TSLA330.241.75
+0.53%
Tesla
AAPL225.120.89
+0.40%
Apple
SPY597.190.29
+0.05%
SPDR® S&P 500® ETF Trust
GME26.46-0.38
-1.42%
GameStop Corp

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with CADL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-5.59%
CADL - INKT
45%
Loosely correlated
+0.23%
NKTR - INKT
36%
Loosely correlated
-8.59%
VINC - INKT
35%
Loosely correlated
-7.50%
CRIS - INKT
28%
Poorly correlated
+1.27%
NUVL - INKT
26%
Poorly correlated
-0.18%
More

VINC and

Correlation & Price change

A.I.dvisor indicates that over the last year, VINC has been loosely correlated with INKT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if VINC jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VINC
1D Price
Change %
VINC100%
-4.54%
INKT - VINC
35%
Loosely correlated
+1.85%
CVKD - VINC
25%
Poorly correlated
-6.60%
CDTX - VINC
25%
Poorly correlated
+3.35%
LEXX - VINC
24%
Poorly correlated
-1.74%
ETXPF - VINC
23%
Poorly correlated
N/A
More